ACCUPRIL
QUINAPRIL HYDROCHLORIDE
Approval overview ACCUPRIL is listed in Drugs@FDA under application 019885 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient QUINAPRIL HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PFIZER PHARMS Submission history Latest submission status date: 2020-05-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview ACCUPRIL is listed in Drugs@FDA under application 019885 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient QUINAPRIL HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PFIZER PHARMS Submission history Latest submission status date: 2020-05-18 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.